NO801496L - PROCEDURE FOR THE PREPARATION OF PYRAZOLD DERIVATIVES - Google Patents
PROCEDURE FOR THE PREPARATION OF PYRAZOLD DERIVATIVESInfo
- Publication number
- NO801496L NO801496L NO801496A NO801496A NO801496L NO 801496 L NO801496 L NO 801496L NO 801496 A NO801496 A NO 801496A NO 801496 A NO801496 A NO 801496A NO 801496 L NO801496 L NO 801496L
- Authority
- NO
- Norway
- Prior art keywords
- pyrazole
- chlorophenyl
- fluorophenyl
- acetic acid
- solution
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- -1 nitro, amino Chemical group 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
- 150000001412 amines Chemical class 0.000 claims description 2
- 150000003217 pyrazoles Chemical class 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 239000011593 sulfur Substances 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 150000007513 acids Chemical class 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 1
- 125000004414 alkyl thio group Chemical group 0.000 claims 1
- FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical group CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 125000004817 pentamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 30
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- UGAGMGHVRQLXKG-UHFFFAOYSA-N 1-(4-chlorophenyl)-n,n-dimethylethenamine Chemical compound CN(C)C(=C)C1=CC=C(Cl)C=C1 UGAGMGHVRQLXKG-UHFFFAOYSA-N 0.000 description 2
- BMMBSROJAOISIS-UHFFFAOYSA-N 1-[4-(4-chlorophenyl)-1-(4-fluorophenyl)pyrazol-3-yl]ethanone Chemical compound CC(=O)C1=NN(C=2C=CC(F)=CC=2)C=C1C1=CC=C(Cl)C=C1 BMMBSROJAOISIS-UHFFFAOYSA-N 0.000 description 2
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 2
- DHEUKGACTBHYCW-UHFFFAOYSA-N 2-[4-(4-chlorophenyl)-1-(4-methylsulfanylphenyl)pyrazol-3-yl]acetic acid Chemical compound ClC1=CC=C(C=C1)C=1C(=NN(C1)C1=CC=C(C=C1)SC)CC(=O)O DHEUKGACTBHYCW-UHFFFAOYSA-N 0.000 description 2
- RMCCCVIYWRJQEW-UHFFFAOYSA-N 4-[2-(4-bromophenyl)ethenyl]morpholine Chemical compound C1=CC(Br)=CC=C1C=CN1CCOCC1 RMCCCVIYWRJQEW-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229950005499 carbon tetrachloride Drugs 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 2
- JQVDAXLFBXTEQA-UHFFFAOYSA-N dibutylamine Chemical compound CCCCNCCCC JQVDAXLFBXTEQA-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- GLYDHOZNBVJYBG-UHFFFAOYSA-N n-(4-fluorophenyl)-2-oxopropanehydrazonoyl chloride Chemical compound CC(=O)C(Cl)=NNC1=CC=C(F)C=C1 GLYDHOZNBVJYBG-UHFFFAOYSA-N 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- BHTZCIGVYSJBQB-UHFFFAOYSA-N 1-(1h-pyrazol-5-yl)ethanone Chemical class CC(=O)C=1C=CNN=1 BHTZCIGVYSJBQB-UHFFFAOYSA-N 0.000 description 1
- SDHFIWNBYPDKTQ-UHFFFAOYSA-N 1-[1,4-bis(4-chlorophenyl)pyrazol-3-yl]ethanone Chemical compound CC(=O)C1=NN(C=2C=CC(Cl)=CC=2)C=C1C1=CC=C(Cl)C=C1 SDHFIWNBYPDKTQ-UHFFFAOYSA-N 0.000 description 1
- YKJUQRWZPARTLM-UHFFFAOYSA-N 1-[4-(4-bromophenyl)-1-(4-fluorophenyl)pyrazol-3-yl]ethanone Chemical compound CC(=O)C1=NN(C=2C=CC(F)=CC=2)C=C1C1=CC=C(Br)C=C1 YKJUQRWZPARTLM-UHFFFAOYSA-N 0.000 description 1
- VMLSODMFKSZXDR-UHFFFAOYSA-N 1-[4-(4-bromophenyl)-2-(4-fluorophenyl)-3-morpholin-4-yl-3,4-dihydropyrazol-5-yl]ethanone Chemical compound CC(=O)C1=NN(C=2C=CC(F)=CC=2)C(N2CCOCC2)C1C1=CC=C(Br)C=C1 VMLSODMFKSZXDR-UHFFFAOYSA-N 0.000 description 1
- ZVPZZMHGAOROCC-UHFFFAOYSA-N 1-[4-(4-chlorophenyl)-1-(4-methylsulfanylphenyl)pyrazol-3-yl]ethanone Chemical compound C1=CC(SC)=CC=C1N1N=C(C(C)=O)C(C=2C=CC(Cl)=CC=2)=C1 ZVPZZMHGAOROCC-UHFFFAOYSA-N 0.000 description 1
- IRGRRSWKJQLVRB-UHFFFAOYSA-N 1-[4-(4-chlorophenyl)-1-phenylpyrazol-3-yl]ethanone Chemical compound CC(=O)C1=NN(C=2C=CC=CC=2)C=C1C1=CC=C(Cl)C=C1 IRGRRSWKJQLVRB-UHFFFAOYSA-N 0.000 description 1
- PQHKAMGAAKGSNW-UHFFFAOYSA-N 1-[4-(4-chlorophenyl)-2-(4-fluorophenyl)-3-morpholin-4-yl-3,4-dihydropyrazol-5-yl]ethanone Chemical compound CC(=O)C1=NN(C=2C=CC(F)=CC=2)C(N2CCOCC2)C1C1=CC=C(Cl)C=C1 PQHKAMGAAKGSNW-UHFFFAOYSA-N 0.000 description 1
- JQZAEUFPPSRDOP-UHFFFAOYSA-N 1-chloro-4-(chloromethyl)benzene Chemical compound ClCC1=CC=C(Cl)C=C1 JQZAEUFPPSRDOP-UHFFFAOYSA-N 0.000 description 1
- WPOYBLWKLDBTBP-UHFFFAOYSA-N 1-morpholin-4-ylethanethione Chemical class CC(=S)N1CCOCC1 WPOYBLWKLDBTBP-UHFFFAOYSA-N 0.000 description 1
- KEQTWHPMSVAFDA-UHFFFAOYSA-N 2,3-dihydro-1h-pyrazole Chemical compound C1NNC=C1 KEQTWHPMSVAFDA-UHFFFAOYSA-N 0.000 description 1
- MFHFWRBXPQDZSA-UHFFFAOYSA-N 2-(4-bromophenyl)acetonitrile Chemical compound BrC1=CC=C(CC#N)C=C1 MFHFWRBXPQDZSA-UHFFFAOYSA-N 0.000 description 1
- MWSNYBOKRSGWAN-UHFFFAOYSA-N 2-(4-chlorophenyl)acetaldehyde Chemical compound ClC1=CC=C(CC=O)C=C1 MWSNYBOKRSGWAN-UHFFFAOYSA-N 0.000 description 1
- QDNFDLUXFADBPV-UHFFFAOYSA-N 2-[1,4-bis(4-chlorophenyl)pyrazol-3-yl]-1-morpholin-4-ylethanethione Chemical compound C1=CC(Cl)=CC=C1C1=CN(C=2C=CC(Cl)=CC=2)N=C1CC(=S)N1CCOCC1 QDNFDLUXFADBPV-UHFFFAOYSA-N 0.000 description 1
- HMQSECTWUFQSPK-UHFFFAOYSA-N 2-[1,4-bis(4-fluorophenyl)pyrazol-3-yl]acetic acid Chemical compound OC(=O)CC1=NN(C=2C=CC(F)=CC=2)C=C1C1=CC=C(F)C=C1 HMQSECTWUFQSPK-UHFFFAOYSA-N 0.000 description 1
- TYBKLPOBJCHOCY-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenyl)-1-(4-fluorophenyl)pyrazol-3-yl]acetic acid Chemical compound OC(=O)CC1=NN(C=2C=CC(F)=CC=2)C=C1C1=CC=C(Cl)C(Cl)=C1 TYBKLPOBJCHOCY-UHFFFAOYSA-N 0.000 description 1
- CUNUHKDDCQBLDQ-UHFFFAOYSA-N 2-[4-(4-bromophenyl)-1-(4-fluorophenyl)pyrazol-3-yl]-1-morpholin-4-ylethanethione Chemical compound C1=CC(F)=CC=C1N1N=C(CC(=S)N2CCOCC2)C(C=2C=CC(Br)=CC=2)=C1 CUNUHKDDCQBLDQ-UHFFFAOYSA-N 0.000 description 1
- NFLKDJLSLPLAGV-UHFFFAOYSA-N 2-[4-(4-bromophenyl)-1-(4-fluorophenyl)pyrazol-3-yl]acetic acid Chemical compound OC(=O)CC1=NN(C=2C=CC(F)=CC=2)C=C1C1=CC=C(Br)C=C1 NFLKDJLSLPLAGV-UHFFFAOYSA-N 0.000 description 1
- CNSPGYKKZSPRQS-UHFFFAOYSA-N 2-[4-(4-chlorophenyl)-1-(4-fluorophenyl)pyrazol-3-yl]-1-morpholin-4-ylethanethione Chemical compound C1=CC(F)=CC=C1N1N=C(CC(=S)N2CCOCC2)C(C=2C=CC(Cl)=CC=2)=C1 CNSPGYKKZSPRQS-UHFFFAOYSA-N 0.000 description 1
- YAMFWQIVVMITPG-UHFFFAOYSA-N 2-[4-(4-chlorophenyl)-1-(4-fluorophenyl)pyrazol-3-yl]acetic acid Chemical compound OC(=O)CC1=NN(C=2C=CC(F)=CC=2)C=C1C1=CC=C(Cl)C=C1 YAMFWQIVVMITPG-UHFFFAOYSA-N 0.000 description 1
- JLBVDJWADOVLAN-UHFFFAOYSA-N 2-[4-(4-chlorophenyl)-1-(4-methylsulfanylphenyl)pyrazol-3-yl]-1-morpholin-4-ylethanethione Chemical compound C1=CC(SC)=CC=C1N1N=C(CC(=S)N2CCOCC2)C(C=2C=CC(Cl)=CC=2)=C1 JLBVDJWADOVLAN-UHFFFAOYSA-N 0.000 description 1
- SOKWKFYFQMCYLX-UHFFFAOYSA-N 2-[4-(4-chlorophenyl)-1-(4-methylsulfinylphenyl)pyrazol-3-yl]acetic acid Chemical compound ClC1=CC=C(C=C1)C=1C(=NN(C1)C1=CC=C(C=C1)S(=O)C)CC(=O)O SOKWKFYFQMCYLX-UHFFFAOYSA-N 0.000 description 1
- WMJZPMJTHUVWSW-UHFFFAOYSA-N 2-[4-(4-chlorophenyl)-1-phenylpyrazol-3-yl]acetic acid Chemical compound OC(=O)CC1=NN(C=2C=CC=CC=2)C=C1C1=CC=C(Cl)C=C1 WMJZPMJTHUVWSW-UHFFFAOYSA-N 0.000 description 1
- VLRGXXKFHVJQOL-UHFFFAOYSA-N 3-chloropentane-2,4-dione Chemical compound CC(=O)C(Cl)C(C)=O VLRGXXKFHVJQOL-UHFFFAOYSA-N 0.000 description 1
- YKFROQCFVXOUPW-UHFFFAOYSA-N 4-(methylthio) aniline Chemical compound CSC1=CC=C(N)C=C1 YKFROQCFVXOUPW-UHFFFAOYSA-N 0.000 description 1
- AOAJHBQTGNMXKH-UHFFFAOYSA-N 4-[2-(4-chlorophenyl)ethenyl]morpholine Chemical compound C1=CC(Cl)=CC=C1C=CN1CCOCC1 AOAJHBQTGNMXKH-UHFFFAOYSA-N 0.000 description 1
- QSNSCYSYFYORTR-UHFFFAOYSA-N 4-chloroaniline Chemical compound NC1=CC=C(Cl)C=C1 QSNSCYSYFYORTR-UHFFFAOYSA-N 0.000 description 1
- IVYMIRMKXZAHRV-UHFFFAOYSA-N 4-chlorophenylacetonitrile Chemical compound ClC1=CC=C(CC#N)C=C1 IVYMIRMKXZAHRV-UHFFFAOYSA-N 0.000 description 1
- KRZCOLNOCZKSDF-UHFFFAOYSA-N 4-fluoroaniline Chemical compound NC1=CC=C(F)C=C1 KRZCOLNOCZKSDF-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- HASGOCLZFTZSTN-UHFFFAOYSA-N cyclohexane;hexane Chemical compound CCCCCC.C1CCCCC1 HASGOCLZFTZSTN-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229940050176 methyl chloride Drugs 0.000 description 1
- RJHCGGWBOWGPJS-UHFFFAOYSA-N n-(4-chlorophenyl)-2-oxopropanehydrazonoyl chloride Chemical compound CC(=O)C(Cl)=NNC1=CC=C(Cl)C=C1 RJHCGGWBOWGPJS-UHFFFAOYSA-N 0.000 description 1
- HOCCFPYBPMPQRB-UHFFFAOYSA-N n-(4-methylsulfanylphenyl)-2-oxopropanehydrazonoyl chloride Chemical compound CSC1=CC=C(NN=C(Cl)C(C)=O)C=C1 HOCCFPYBPMPQRB-UHFFFAOYSA-N 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- IYJCSNRIDBJVRP-UHFFFAOYSA-M sodium;2-[4-(4-chlorophenyl)-1-(4-fluorophenyl)pyrazol-3-yl]acetate Chemical compound [Na+].[O-]C(=O)CC1=NN(C=2C=CC(F)=CC=2)C=C1C1=CC=C(Cl)C=C1 IYJCSNRIDBJVRP-UHFFFAOYSA-M 0.000 description 1
- DGPIGKCOQYBCJH-UHFFFAOYSA-M sodium;acetic acid;hydroxide Chemical compound O.[Na+].CC([O-])=O DGPIGKCOQYBCJH-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Foreliggende oppfinnelse angår en fremgangsmåte ved fremstilling av forbindelsene angitt i krav 11 The present invention relates to a method for producing the compounds specified in claim 11
Pyrazolderivater med den generelle formel I ifølge krav 1 er kjent fra,tysk patentansøkning P 26 33 992, men deres fremstilling ved de kjente fremgangsmåter er meget kostbar, og de erholdte utbytter er ofte utilfredsstillende. Pyrazole derivatives of the general formula I according to claim 1 are known from German patent application P 26 33 992, but their production by the known methods is very expensive, and the yields obtained are often unsatisfactory.
Ved foreliggende fremgangsmåte lykkes det derimot å fremstille pyrazdlderivatene med den generelle formel I ved en enkel syntese i gode utbytter. The present method, on the other hand, succeeds in preparing the pyrazdl derivatives of the general formula I by a simple synthesis in good yields.
Foreliggende fremgangsmåte utføres under i og for seg kjente betingelser (Org. Reactions, ^3, (1946) , 83-107; Angew. Chem., 70, (1958), 351-367 og Synthesis (1975), 358-375). The present method is carried out under conditions known per se (Org. Reactions, ^3, (1946), 83-107; Angew. Chem., 70, (1958), 351-367 and Synthesis (1975), 358-375) .
Foreliggende fremgangsmåte utføres i nærvær av primære eller sekundære aminer.. Egnede aminer er f. eks. methylamin, ethylamin, dimethylamin, diethylamin, dibutylamin, anilin, The present method is carried out in the presence of primary or secondary amines. Suitable amines are e.g. methylamine, ethylamine, dimethylamine, diethylamine, dibutylamine, aniline,
a-, 3- eller Y-Picolin'piperidin eller særlig morfolin og pyrrolidin. α-, 3- or Y-Picolin' piperidine or especially morpholine and pyrrolidine.
De følgende utførelseseksempler tjener til å belyse oppfinnelsen ytterligere. The following exemplary embodiments serve to further illustrate the invention.
Eksempel 1Example 1
a) 28,9 g 4-fluoranilin tilsettes 260 ml 15%-ig saltsyre og 260 g is, avkjøles til -5°C og diazoteres med 19,7 g a) 28.9 g of 4-fluoroaniline is added to 260 ml of 15% hydrochloric acid and 260 g of ice, cooled to -5°C and diazotized with 19.7 g
natriumnitrit i 50 ml vann. Under stadig omrøring og av-kjøling tildryppes en oppløsning av 38,4 g 3-klor-2,4-pentan-dion, 260 ml ethanol, 260 g isvann og 350 g natriumacetat-hydrat. Blandingen omrøres i ytterligere 3 timer ved 0°C, fortynnes så med vann, hvorved forbindelsen utkrystalliserer. Krystallresiduet omkrystalliseres fra ethanol, og man får 50 g 1-klor-l-(4-fluorfenylhydrazono)-2-propanon med smp. 148°C. sodium nitrite in 50 ml of water. With constant stirring and cooling, a solution of 38.4 g of 3-chloro-2,4-pentanedione, 260 ml of ethanol, 260 g of ice water and 350 g of sodium acetate hydrate is added dropwise. The mixture is stirred for a further 3 hours at 0°C, then diluted with water, whereby the compound crystallizes out. The crystal residue is recrystallized from ethanol, and 50 g of 1-chloro-1-(4-fluorophenylhydrazono)-2-propanone with m.p. 148°C.
b) En oppløsning av 19,6 g 4-brombenzylcyanid i 100 ml toluen blir ved -10°C under nitrogen tilsatt dråpevis 108 ml b) A solution of 19.6 g of 4-bromobenzyl cyanide in 100 ml of toluene is added dropwise to 108 ml at -10°C under nitrogen
av en 20%-ig oppløsning av diisobutylaluminiumhydrid (Dibah)of a 20% solution of diisobutylaluminum hydride (Dibah)
i toluen<p>g omrøres så i ytterligere 15 minutter. Efter forsiktig tilsetning av 35 ml ethanol tilsettes 250 ml vann og ca. 20 ml konsentrert svovelsyre (til pH 2), og der omrøres i 15 minutter ved 0°C. Derefter fraskilles toluenfasen, og in toluene<p>g is then stirred for a further 15 minutes. After carefully adding 35 ml of ethanol, add 250 ml of water and approx. 20 ml of concentrated sulfuric acid (to pH 2), and stir for 15 minutes at 0°C. The toluene phase is then separated, and
vannfasen efterekstraheres med toluen, de forenede toluen-oppløsninger vaskes med vann og tørres over magnesiumsulfat. Efter filtrering tilsettes toluenoppløsningen av 4-klorfényl-acetaldehyd 78 g morfolin, og der inndampes langsomt til halvt volum i vakuum og hensettes over natten. Efter inn-dampning av oppløsningen omrøres residuet med cyclohexan, hvorved krystallisasjon skjer. Krystallisatet omkrystalliseres så fra diisopropylether, og man får 12 g 4-(4-brom-styryl)-morfolin med smp. 142°C. c) En oppløsning av 7,2 g 4-(4-bromstyryl)-morfolin i 30 ml kloroform tilsettes efter hverandre med 2,7 g triethyl-amin og en oppløsning av 5,3 g 1-klor-l-(4-fluorfenylhydra-zono)-2-propanon i 30 ml kloroform og omrøres over natten ved værelsetemperatur (alternativt kan der kokes under til-bakeløp i 4 timer). Efter vasking med 2N saltsyre, natrium-hydrogencarbonatoppløsning og vann tørres kloroformfasen med magnesiumsulfat og inndampes. Det fra hexan (cyclohexan) krystalliserte residuum (10,5 g) kan enten videreopparbeides eller omkrystalliseres nok en gang fra ethanol; og man får 3-acetyl-4-(4-bromfenyl)-1-(4-fluorfenyl)-5-morfolino-4,5-dihydropyrazol med smp. 148°C. d) En oppløsning av 10 g av ovennevnte dihydropyrazol i 110 ml dioxan kokes med 30 ml 2N saltsyre i 60-90 minutter the water phase is subsequently extracted with toluene, the combined toluene solutions are washed with water and dried over magnesium sulphate. After filtration, 78 g of morpholine are added to the toluene solution of 4-chlorophenylacetaldehyde, which is slowly evaporated to half the volume in a vacuum and allowed to stand overnight. After evaporation of the solution, the residue is stirred with cyclohexane, whereby crystallization takes place. The crystallisate is then recrystallized from diisopropyl ether, and 12 g of 4-(4-bromo-styryl)-morpholine with m.p. 142°C. c) A solution of 7.2 g of 4-(4-bromostyryl)-morpholine in 30 ml of chloroform is added successively with 2.7 g of triethylamine and a solution of 5.3 g of 1-chloro-1-(4- fluorophenylhydra-zono)-2-propanone in 30 ml of chloroform and stirred overnight at room temperature (alternatively, it can be boiled under reflux for 4 hours). After washing with 2N hydrochloric acid, sodium bicarbonate solution and water, the chloroform phase is dried with magnesium sulphate and evaporated. The residue crystallized from hexane (cyclohexane) (10.5 g) can either be further worked up or recrystallized once more from ethanol; and 3-acetyl-4-(4-bromophenyl)-1-(4-fluorophenyl)-5-morpholino-4,5-dihydropyrazole is obtained with m.p. 148°C. d) A solution of 10 g of the above-mentioned dihydropyrazole in 110 ml of dioxane is boiled with 30 ml of 2N hydrochloric acid for 60-90 minutes
under tilbakeløp. Derpå inndampes i vakuum, residuet taes opp i ethylacetat, vaskes med vann, tørres med magnesiumsulfat og inndampes i vakuum. Residuet krystalliseres fra methanol, og man får 7,5 g 3-acetyl-4-(4-bromfenyl)-1-(4-fluorfenyl)-pyrazol med smp. 185°C. during reflux. It is then evaporated in vacuo, the residue is taken up in ethyl acetate, washed with water, dried with magnesium sulfate and evaporated in vacuum. The residue is crystallized from methanol, and 7.5 g of 3-acetyl-4-(4-bromophenyl)-1-(4-fluorophenyl)-pyrazole with m.p. 185°C.
e) En blanding av 7,2 g av 3-acetylpyrazol-dérivatet og 0,84 g svovel oppvarmes i 9 ml morfolin i 3-4 timer ved e) A mixture of 7.2 g of the 3-acetylpyrazole derivative and 0.84 g of sulfur is heated in 9 ml of morpholine for 3-4 hours at
135°C, helles så i 150 ml isvann og omrøres godt. Det av-sugede bunnfall krystalliseres fra ethylacetat og dioxan, og man får 7,8 g 4-[4-(4-bromfenyl)-1-(4-fluorfenyl)-3-pyrazolyl-thioacetyl]-morfolin med smp. 211°C. 135°C, then pour into 150 ml of ice water and stir well. The aspirated precipitate is crystallized from ethyl acetate and dioxane, and 7.8 g of 4-[4-(4-bromophenyl)-1-(4-fluorophenyl)-3-pyrazolyl-thioacetyl]-morpholine are obtained with m.p. 211°C.
f) En blanding av 7,4 g ifølge eksempel ld fremstilt thio-acetylmorfolinderivat i 20 ml dimethylsulfoxyd tilsettes 6,4 g f) A mixture of 7.4 g of the thio-acetylmorpholine derivative prepared according to example 1d in 20 ml of dimethylsulfoxide is added to 6.4 g
natriumhydroxyd i 30 ml vann og oppvarmes under tilbakeløp i 5 timer. Efter helling i isvann krystalliserer natriumsaltet ut, avsuges, vaskes med methylehklorid og suspenderes i 2N saltsyre. Man får 5 g 4-(4-bromfenyl)-1-(4-fluorfenyl)-3-pyråzol-eddiksyre med smp. 175°C. sodium hydroxide in 30 ml of water and heated under reflux for 5 hours. After pouring into ice water, the sodium salt crystallizes out, filtered off with suction, washed with methyl chloride and suspended in 2N hydrochloric acid. 5 g of 4-(4-bromophenyl)-1-(4-fluorophenyl)-3-pyrazole-acetic acid with m.p. 175°C.
Eksempel 2 Example 2
Analogt med eksempel 1 fåes 4-(4-klorfenyl)-1-(.4-fluorfenyl)-3-pyrazol-eddiksyre med smp. 148°C (ethanol/vann). Analogous to example 1, 4-(4-chlorophenyl)-1-(.4-fluorophenyl)-3-pyrazole-acetic acid is obtained with m.p. 148°C (ethanol/water).
De anvendte mellomprodukter er: 4-(4-klorstyryl)-morfolin med smp. 102°C (diisopropylether) (fremstilt analogt med eksempel lb fra 4-klorbenzyl-cyanid) The intermediates used are: 4-(4-chlorostyryl)-morpholine with m.p. 102°C (diisopropyl ether) (prepared analogously to example 1b from 4-chlorobenzyl cyanide)
3-acetyl-4-(4-klorfenyl)-1-(4-fluorfenyl)-5-morfolino-4,5-dihydropyrazol, smp. 137°C (ethanol) 3-acetyl-4-(4-chlorophenyl)-1-(4-fluorophenyl)-5-morpholino-4,5-dihydropyrazole, m.p. 137°C (ethanol)
3- acetyl-4-(4-klorfenyl)-1-(4-fluorfenyl)-pyrazol, smp. 181°C (isopropylalkohol) 4- [4-(4-klorfenyl)-1-(4-fluorfenyl)-3-pyrazolyl-thio-acetyl]-morfolin, smp;. 213°C (dioxan) 3- acetyl-4-(4-chlorophenyl)-1-(4-fluorophenyl)-pyrazole, m.p. 181°C (isopropyl alcohol) 4-[4-(4-chlorophenyl)-1-(4-fluorophenyl)-3-pyrazolyl-thio-acetyl]-morpholine, m.p. 213°C (dioxane)
4-(4-klorfenyl)-1-(4-fluorfenyl)-3-pyrazol-eddiksyre-natriumsalt, smp. 299°C (vann). 4-(4-chlorophenyl)-1-(4-fluorophenyl)-3-pyrazole-acetic acid sodium salt, m.p. 299°C (water).
Fremstillingen av 3-acetyl-4-(4-klorfenyl)-1-(4-fluor-fenyl) -pyrazol kan også skje analogt med eksempel lc fra a-dimethylamino-4-klorstyren og 1-klor-l-(4-fluorfenyl-hydrazono)-propan-2-on. The production of 3-acetyl-4-(4-chlorophenyl)-1-(4-fluoro-phenyl)-pyrazole can also take place analogously to example 1c from α-dimethylamino-4-chlorostyrene and 1-chloro-1-(4- fluorophenyl-hydrazono)-propan-2-one.
Utgangsmaterialet, a-dimethylamino-4-klorstyren, kan også fåes på følgende måte: The starting material, α-dimethylamino-4-chlorostyrene, can also be obtained in the following way:
En oppløsning av 8 g 4-klorbenzylklorid i 50 ml ether tilsettes dråpevis til 1,5 g magnesiumspon (under argon) og omrøres så i 30 minutter. Derpå avkjøles oppløsningen til -15°G og tilsettes dråpevis med 11 g rent dimethylformamid og 30 ml tetrahydrofuran. Reaksjonsblandingen omrøres i 3 timer ved -15°C, inndampes så forsiktig i vakuum og tilsettes 50 ml 2N ammoniumkloridoppløsning såvel som ethylacetat. Det organ-iske residuum krystalliseres fra methanol, og man får 5 g ct-dimethylamino-4-klorstyren med smp. 77°C. Eksempel 3 A solution of 8 g of 4-chlorobenzyl chloride in 50 ml of ether is added dropwise to 1.5 g of magnesium shavings (under argon) and then stir for 30 minutes. The solution is then cooled to -15°G and 11 g of pure dimethylformamide and 30 ml of tetrahydrofuran are added dropwise. The reaction mixture is stirred for 3 hours at -15°C, then carefully evaporated in vacuo and 50 ml of 2N ammonium chloride solution as well as ethyl acetate are added. The organic residue is crystallized from methanol, and 5 g of ct-dimethylamino-4-chlorostyrene with m.p. 77°C. Example 3
Analogt med eksempel 1 fremstilles 1,4-bis-(4-klor-. fenyl)-3-pyrazol-l-eddiksyre med smp. 184°C (toluen). Analogous to example 1, 1,4-bis-(4-chloro-.phenyl)-3-pyrazole-1-acetic acid is prepared with m.p. 184°C (toluene).
De anvendte mellomprodukter er: The intermediate products used are:
1-klor-l-,(4-klorfenylhydrazono)-2-propanon,1-chloro-1-(4-chlorophenylhydrazono)-2-propanone,
smp. 175°C (ethanol) (fremstilt analogt med eksempel- la fra 4-kloranilin). m.p. 175°C (ethanol) (prepared analogously to example 1a from 4-chloroaniline).
3- acetyl-l,4-bis-(4-klorfenyl)-pyrazol, smp. 190°C 3-acetyl-1,4-bis-(4-chlorophenyl)-pyrazole, m.p. 190°C
(dioxan)(dioxane)
4- [1,4-bis-(4-klorfenyl)-3-pyrazolyl-thioacetyl]-morfolin, smp. 204°C (dioxan) 4-[1,4-bis-(4-chlorophenyl)-3-pyrazolyl-thioacetyl]-morpholine, m.p. 204°C (dioxane)
Eksempel 4Example 4
Analogt med eksempel 1 fremstilles 4-(4-klorfenyl)-1-(4-methylthiofenyl)-3-pyrazol-eddiksyre med smp. 169°C (methanol). Analogous to example 1, 4-(4-chlorophenyl)-1-(4-methylthiophenyl)-3-pyrazole-acetic acid is prepared with m.p. 169°C (methanol).
De anvendte mellomprodukter er: 1-klor-l-(4-methylthiofenylhydrazono)-2-propanon, smp. 110°C (tetraklormethan); (fremstilt analogt med eksempel la fra 4-methylthioanilin). The intermediates used are: 1-chloro-1-(4-methylthiophenylhydrazono)-2-propanone, m.p. 110°C (tetrachloromethane); (prepared analogously to example 1a from 4-methylthioaniline).
3- acetyl-4-(4-klorfenyl)-1-(4-methylthiofenyl)-pyrazol, smp. 85°C (methanol) 3- acetyl-4-(4-chlorophenyl)-1-(4-methylthiophenyl)-pyrazole, m.p. 85°C (methanol)
4- [4-(4-klorfenyl)-1-(4-methylthiofenyl)-3-pyrazolyl-thioacetyl ] -morfolin, smp. 248°C (ethylacetat) 4-[4-(4-chlorophenyl)-1-(4-methylthiophenyl)-3-pyrazolyl-thioacetyl]-morpholine, m.p. 248°C (ethyl acetate)
Eksempel 5Example 5
En oppløsning av 1,8 g 4-(4-klorfenyl)-1-(4-methylthio-fenyl)-3-pyrazol-eddiksyre (fremstilt ifølge eksempel 4) i en blanding av 20 ml kloroform og 20 ml eddiksyre tilsettes 1 ml hydrogenperoxyd (30%) og omrøres ved værelsetemperatur i A solution of 1.8 g of 4-(4-chlorophenyl)-1-(4-methylthio-phenyl)-3-pyrazole-acetic acid (prepared according to example 4) in a mixture of 20 ml of chloroform and 20 ml of acetic acid is added to 1 ml hydrogen peroxide (30%) and stirred at room temperature i
1 time. Derpå fortynnes med vann, hvorved forbindelsen 1 hour. It is then diluted with water, whereby the compound
krystalliserer ut. Den krystallinske forbindelse avsuges, vaskes med varmt vann og omkrystalliseres fra methanol, og man får 1,4 g 4-(4-klorfenyl)-1-(4-methylsulfinylfenyl)-3-pyrazol-eddiksyre med smp. 193°C. crystallizes out. The crystalline compound is filtered off, washed with hot water and recrystallized from methanol, and 1.4 g of 4-(4-chlorophenyl)-1-(4-methylsulfinylphenyl)-3-pyrazole-acetic acid with m.p. 193°C.
Eksempel 6Example 6
Analogt med eksempel 1 fremstilles 4-(4-klorfenyl)-1-fenyl-3-pyrazol-eddiksyre med smp. 169°C (toluen). Analogous to example 1, 4-(4-chlorophenyl)-1-phenyl-3-pyrazole-acetic acid is prepared with m.p. 169°C (toluene).
De anvendte mellomprodukter er: 1-klor-l-fenylhydrazono-2-propanon, smp. 136°C The intermediates used are: 1-chloro-1-phenylhydrazono-2-propanone, m.p. 136°C
(ethanol)(ethanol)
3- acetyl-4-(4-klorfenyl)-1-fenyl-pyrazol,3- acetyl-4-(4-chlorophenyl)-1-phenyl-pyrazole,
smp. 101°C (methanol) m.p. 101°C (methanol)
4- [4- (4-klorfenyl)-1-fenyl-3-pyrazblylthioacetyl]-morfolin, smp. 205°C (dioxan).. 4-[4-(4-chlorophenyl)-1-phenyl-3-pyrazblylthioacetyl]-morpholine, m.p. 205°C (dioxane)..
Eksempel 7Example 7
En oppløsning av 2 g 4-(4-klorfenyl)-1-(4-fluorfenyl)-3-pyrazol-eddiksyre (fremstilt ifølge eksempel 2) i 30 ml dimethylformamid tilsettes en oppløsning av 600 mg kobber(II)-acetat i 35 ml dimethylformamid og omrøres i 8 timer ved værelsetemperatur. Efter avdestillering av oppløsnings-midlet i vakuum oppløses det oljeaktige residuum i aceton, og residuet frafiltreres. Efter fordampning av acetonet krystalliseres saltresiduet fra methanol. Man får 1,7 g 4-(4-klorfenyl)-1-(4-fluorfenyl)-3-pyrazoleddiksyre-kobber(II)-salt-monohydrat med smp. 171°C. A solution of 2 g of 4-(4-chlorophenyl)-1-(4-fluorophenyl)-3-pyrazole-acetic acid (prepared according to example 2) in 30 ml of dimethylformamide is added to a solution of 600 mg of copper (II) acetate in 35 ml of dimethylformamide and stirred for 8 hours at room temperature. After distilling off the solvent in vacuum, the oily residue is dissolved in acetone, and the residue is filtered off. After evaporation of the acetone, the salt residue is crystallized from methanol. 1.7 g of 4-(4-chlorophenyl)-1-(4-fluorophenyl)-3-pyrazoleacetic acid copper(II) salt monohydrate with m.p. 171°C.
Eksempel 8Example 8
Analogt med eksempel 1 fremstilles 1,4-bis-(4-fluor-fenyl) -3-pyrazol-eddiksyre (smp. 116°C fra tetraklormethan). Analogous to example 1, 1,4-bis-(4-fluoro-phenyl)-3-pyrazole-acetic acid (m.p. 116°C from tetrachloromethane) is prepared.
Eksempel 9Example 9
Analogt med eksempel 1 fremstilles 4-(2,4-diklorfenyl)-1-(4-f luorf enyl)-3-pyrazoleddiksyre ..(smp. 133°C fra toluen). Analogously to example 1, 4-(2,4-dichlorophenyl)-1-(4-fluorophenyl)-3-pyrazoleacetic acid is prepared (m.p. 133°C from toluene).
Eksempel 10Example 10
Analogt med eksempel 1 fremstilles 1-(2-fluorfenyl)-4-(4-nitrofenyl)-3-pyrazol-eddiksyre (smp. 208°C fra eddiksyre-ethylester). Analogous to example 1, 1-(2-fluorophenyl)-4-(4-nitrophenyl)-3-pyrazole-acetic acid is prepared (m.p. 208°C from acetic acid ethyl ester).
Eksempel 11Example 11
Analogt med eksempel 1 fremstilles 4-(4-klorfenyl)-1-(2-fluorfenyl)-3-pyrazol-eddiksyre (smp. 187°C fra eddiksyre-ethylester). Analogous to example 1, 4-(4-chlorophenyl)-1-(2-fluorophenyl)-3-pyrazole-acetic acid (m.p. 187°C from acetic acid ethyl ester) is prepared.
Eksempel 12Example 12
Analogt med eksempel 1 fremstilles 1-(4-fluorfenyl)-4-(4-nitrofenyl)-3-pyrazol-eddiksyre (smp. 254°C fra aceto- Analogously to example 1, 1-(4-fluorophenyl)-4-(4-nitrophenyl)-3-pyrazole-acetic acid (m.p. 254°C) is prepared from aceto-
4- • nitril). 4- • nitrile).
Eksempel 13Example 13
Analogt med eksempel 1 fremstilles 4-(3,4-diklorfenyl)-1-(4-fluorfenyl)-3-pyrazol-eddiksyre (smp. 178°C fra toluen). Analogous to example 1, 4-(3,4-dichlorophenyl)-1-(4-fluorophenyl)-3-pyrazole-acetic acid is prepared (m.p. 178°C from toluene).
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19792920941 DE2920941A1 (en) | 1979-05-21 | 1979-05-21 | 3-Pyrazole-acetic acid deriv. prepn. - by reacting 3-acetyl-pyrazole deriv. with sulphur and amine and hydrolysing the pyrazolyl-thio-acetyl deriv. |
Publications (1)
Publication Number | Publication Date |
---|---|
NO801496L true NO801496L (en) | 1980-11-24 |
Family
ID=6071550
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO801496A NO801496L (en) | 1979-05-21 | 1980-05-20 | PROCEDURE FOR THE PREPARATION OF PYRAZOLD DERIVATIVES |
Country Status (6)
Country | Link |
---|---|
DE (1) | DE2920941A1 (en) |
DK (1) | DK151626C (en) |
FI (1) | FI77655C (en) |
GR (1) | GR68455B (en) |
HU (1) | HU185383B (en) |
NO (1) | NO801496L (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE748539C (en) * | 1941-01-16 | 1944-11-06 | Process for the preparation of the amides of heterocyclically substituted acetic acids or the free acids |
-
1979
- 1979-05-21 DE DE19792920941 patent/DE2920941A1/en not_active Withdrawn
-
1980
- 1980-05-19 GR GR61980A patent/GR68455B/el unknown
- 1980-05-20 NO NO801496A patent/NO801496L/en unknown
- 1980-05-20 DK DK219180A patent/DK151626C/en not_active IP Right Cessation
- 1980-05-20 HU HU801259A patent/HU185383B/en unknown
- 1980-05-21 FI FI801639A patent/FI77655C/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK219180A (en) | 1980-11-22 |
DK151626B (en) | 1987-12-21 |
FI77655B (en) | 1988-12-30 |
GR68455B (en) | 1981-12-30 |
HU185383B (en) | 1985-01-28 |
FI801639A (en) | 1980-11-22 |
DE2920941A1 (en) | 1980-11-27 |
DK151626C (en) | 1988-07-18 |
FI77655C (en) | 1989-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU649312A3 (en) | Method of obtaining 4-(polyalkoxyphenyl)-2-pyrrolidones | |
CA2101521A1 (en) | 5-heteroyl indole derivatives | |
SE452610B (en) | SETTING DIVERSE RACEMIC CIS-1,2-CYCLOPROPANDICARBOXYLIC ACID DERIVATIVES | |
SK286143B6 (en) | Process for preparing mesylates of piperazine derivatives and compounds prepared in such a manner | |
HU197881B (en) | Process for producing new carbamoyl-oxy-alkyl-carboxy-lic acid derivatives | |
CN112390725B (en) | Preparation method of amide compound | |
US4820847A (en) | Process for the preparation of 4-substituted 1-aryl-5-amino-pyrazoles | |
JP6256484B2 (en) | Method for producing pyridazine compound | |
EP2118058B1 (en) | Method for the preparation of 5-benzyloxy-2-(4-benzyloxphenyl)-3-methyl-1h-indole | |
JP6251197B2 (en) | Process for preparing substituted phenylpropanones | |
NO801496L (en) | PROCEDURE FOR THE PREPARATION OF PYRAZOLD DERIVATIVES | |
US4200759A (en) | Preparation of imidazo[2,1-a]isoindole compounds | |
US4864032A (en) | Process for the preparation of indazoles | |
HU196955B (en) | Process for producing substituted phenyl-hydrazine derivatives | |
JPH01197472A (en) | Production of 5-amino-1-phenyl-4-nitropyrazoles | |
CS219280B2 (en) | Method of making the pyrazol derivatives | |
JP2021526142A (en) | Process for preparing 2- (1- (tert-butoxycarbonyl) piperidine-4-yl) benzoic acid | |
CN111807997A (en) | Synthesis method of N- (4-methoxycarbonyl-3-aminosulfonylbenzyl) methanesulfonamide | |
JPS63192748A (en) | Manufacture of 2-cyano-2-oxyiminoacetamide | |
CH616659A5 (en) | ||
NO139479B (en) | PROCEDURE FOR THE PREPARATION OF 4-AMINO-3,5-DIHALOGEN-PHENYL-ETHANOLAMINES | |
CA2456531C (en) | Process for the preparation of 4-(imidazole-1-yl)benzenesulfonamide derivatives | |
WO2002060861A1 (en) | Benzamidine derivatives and process for production thereof | |
EP0036684A1 (en) | Derivatives of 4-methyl-5-(2-aminoethyl)-thiomethyl-imidazole having therapeutic activity | |
US4977274A (en) | 4-hydroxyindole derivatives, the process for preparation thereof and their use |